1. Home
  2. FEMY vs ATCH Comparison

FEMY vs ATCH Comparison

Compare FEMY & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.42

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.27

Market Cap

34.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEMY
ATCH
Founded
2004
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
34.9M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
FEMY
ATCH
Price
$0.42
$0.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.50
$1.00
AVG Volume (30 Days)
548.6K
2.8M
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
44.71
N/A
EPS
N/A
0.06
Revenue
$2,293,313.00
N/A
Revenue This Year
$105.16
N/A
Revenue Next Year
$200.23
N/A
P/E Ratio
N/A
$4.22
Revenue Growth
40.77
N/A
52 Week Low
$0.31
$0.14
52 Week High
$1.29
$1.92

Technical Indicators

Market Signals
Indicator
FEMY
ATCH
Relative Strength Index (RSI) 41.99 69.47
Support Level $0.33 $0.24
Resistance Level $0.58 $0.28
Average True Range (ATR) 0.05 0.02
MACD 0.00 0.01
Stochastic Oscillator 72.46 93.31

Price Performance

Historical Comparison
FEMY
ATCH

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: